Clinical trial
GRK4 Polymorphisms Blood Pressure Response to Candesartan
NCT01629225 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GRK4 Polymorphisms Blood Pressure Response to Candesartan
- Lead sponsor
- Third Military Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- July 31, 2015
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.